Records containing: Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Multi-institutional Prospective Pilot Study of Radiology Evaluation of Acute Leukemia Infiltration analyZed by Experimental Imaging
-
CLINICAL_TRIALS study record update · 2026-04-20A Retrospective Study of Clinical Outcomes in Newly Diagnosed, Transplant Ineligible Multiple Myeloma Patients Treated With Daratumumab, Lenalidomide and Dexamethasone (DRd) Outside of Clinical Trials in the UK
-
CLINICAL_TRIALS study record update · 2026-04-13Open-label, Single-arm, Phase 2 Study of Initial Treatment With Daratumumab (Darzalex), Carfilzomib (Kyprolis), Lenalidomide (Revlimid) and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma Requiring Systemic Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-04-06Randomized Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone to High-Dose Treatment With ASCT in the Initial Management of Myeloma in Patients up to 65 Years of Age
-
CLINICAL_TRIALS study record update · 2026-04-06Relevance of Maintenance Therapy Using Lenalidomide (Revimid®) After Autologous Stem Cell Transplantation Patients Under the Age Of 65. (Open, Randomised, Multi-centric Trial Versus Placebo).
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-31Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-03-30Evaluation of Skin Tests in Biotherapy Allergies
-
CLINICAL_TRIALS study record update · 2026-03-23Phase 2 Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant Consolidation and Maintenance for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-03-11Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-03-04Chimeric Antigen Receptor Treatment Targeting Lymphoma, Myeloma and Solid Tumors That Express CD70 (SEventY) CALySSEY
-
CLINICAL_TRIALS study record update · 2026-02-20The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial
-
CLINICAL_TRIALS study record update · 2026-02-10A Phase 1 Study of KTX-1001, an Oral, First-In-Class, Selective, and Potent MMSET Catalytic Inhibitor That Suppresses H3K36me2 in Patients With Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-02-10Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
-
CLINICAL_TRIALS study record update · 2026-02-05Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-01-15Removing Transfusion Dependence as a Barrier to Hospice Enrollment
-
CLINICAL_TRIALS study record update · 2026-01-15PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-01-07Non-Invasive Minimal Residual Disease (MRD) Assessment in Multiple Myeloma Via Functional Imaging and Liquid Biopsy
-
CLINICAL_TRIALS study record update · 2025-12-23Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults
-
CLINICAL_TRIALS study record update · 2025-12-19Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning (IFM 2005-03)
-
CLINICAL_TRIALS study record update · 2025-12-18A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma (BELLA)
-
CLINICAL_TRIALS study record update · 2025-12-15A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
-
CLINICAL_TRIALS study record update · 2025-12-12A Phase I Study of FT576 as Monotherapy and in Combination With Daratumumab in Subjects With Relapsed/Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-11A Phase I/II Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-04A Phase I Study of Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy
-
CLINICAL_TRIALS study record update · 2025-12-03Phase II Study of Elranatamab as Maintenance Therapy Post Ciltacabtagene-autoleucel(Cilta-cel) in Patients With Clinical High Risk Relapsed Myeloma